GSK Annual Report 2002

GlaxoSmithKline gave unrestricted gifts of $10 million to the
University of Pennsylvania and $5 million to Duke University. The
gifts will be used to support their discovery research efforts to
identify and develop new treatments for disease.
Science in the Summer is a library-based science education
programme in the Philadelphia area offering hands-on courses
taught by certified teachers. A GlaxoSmithKline grant of $400,000
to the American Association for the Advancement of Science
supports this programme.
In North Carolina, Duke University Medical Center received a
$250,000 grant over two years to expand their adult diabetes
education programme’s outreach to minority and underserved
populations.
With a $250,000 contribution over five years, the Rescue Missions
Ministry will set up a GlaxoSmithKline educational scholarship
endowment for formerly homeless people.
The University of North Carolina at Chapel Hill received $250,000
as part of an overall $1.25 million grant for a travelling science and
technology bus to help improve science teaching and to encourage
and advance the science careers of underserved and ethnic
minority students.
International
GlaxoSmithKline’s International Community Partnerships
programmes addressed health education and mobilisation,
providing partnership funding of £1.1 million in 2002. Programmes
included:
£320,000 to support its PHASE initiative (Personal Hygiene
And Sanitation Education) in Kenya, Uganda, Nicaragua and
Peru. PHASE targets school children and aims to reduce
diarrhoea-related disease and death.
£100,000 as part of a three-year commitment to fund an
HIV/AIDS clinic in the Masoyi tribal area of Mpumalanga,
South Africa.
The Group extended its Rural Nursing Excellence programme in
Thailand, which sponsors female high school graduates from rural
areas to complete four-year nursing degrees. GlaxoSmithKline has
donated another £100,000 to train a further 50 nurses.
In Ethiopia GlaxoSmithKline provided £100,000 for the Integrated
Management of Childhood Illnesses (IMCI) in partnership with the
WHO and UNICEF. The goal is to contribute to the global reduction
of mortality and morbidity in children under the age of five from
pneumonia, diarrhoea, malaria, measles and malnutrition.
In China, £100,000 of GlaxoSmithKline funding is supporting the
development of a community-based HIV/AIDS programme in
collaboration with the Red Cross Movement in China, British Red
Cross and Australian Red Cross.
Description of business GlaxoSmithKline 29
Product donations
GlaxoSmithKline donates essential products for humanitarian relief
efforts. Donations are made at the request of governments and
major charitable organisations and are generally manufactured
specifically to meet these requests. NGOs complete a needs
assessment and then order the product needed in their
international communities. This ensures that the right product
reaches the right person at the right time.
In 2002, the total value of the Group’s international product
donations, excluding the lymphatic filariasis programme, was
$23.4 million, at wholesale acquisition cost. This is
GlaxoSmithKline’s wholesale list price, not including discounts and
is a standard industry method of valuing product donations.
Employee involvement
GlaxoSmithKline employees are encouraged to contribute to their
local communities through employee volunteering schemes.
Support for this varies around the world but includes employee
time, donations to charities where employees have completed
voluntary work and a matching gifts programme. In 2002, in the
USA, the Group matched more than 9,000 employee gifts, at a
value of $3.1 million.
GlaxoSmithKline also matched contributions by employees to the
United Way campaigns at a value of $1.6 million. This was further
supplemented by GlaxoSmithKline’s three year grant of $555,000
to the United Way of Southeastern Pennsylvania which provides
specific capacity building grants and creates more effective
healthcare delivery at the United Way’s 91 member agencies.
GlaxoSmithKline’s Investment in Volunteer Excellence (GIVE)
provided $500 grants to qualifying US non-profit organisations
based on employee or partner volunteer time. The GIVE grants
totalled $145,000 and reflect over 34,000 employee volunteer
hours.
Foundations
The Group does not operate a single charitable foundation for its
corporate programmes but has a number of country-based
foundations including:
The GlaxoSmithKline France Foundation supports programmes to
improve HIV/AIDS prevention education, training and care,
primarily in Africa. As a result, over 200,000 people are expected
to access care and support services by the end of 2005.
The North Carolina GlaxoSmithKline Foundation is an endowed,
self-funding organisation which operates as a separate entity. The
foundation publishes its own annual report, which is available on
request, and uses its asset base to support math, science and
health education in North Carolina. In 2002, this foundation made
donations totalling $2.2 million. This figure is not included in the
Group’s total community investment figure.